F517-0326 Screening compound: 3,4,5-trimethoxy-N-[2-(piperidin-1-yl)-5-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide

F517-0326 Screening compound: 3,4,5-trimethoxy-N-[2-(piperidin-1-yl)-5-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide
F517-0326 Screening compound: 3,4,5-trimethoxy-N-[2-(piperidin-1-yl)-5-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F517-0326
3,4,5-trimethoxy-N-[2-(piperidin-1-yl)-5-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F517-0326

Molecular Formula

C22H26N6O4 (C22 H26 N6 O4)

Compound Name

3,4,5-trimethoxy-N-[2-(piperidin-1-yl)-5-(1H-1,2,3,4-tetrazol-1-yl)phenyl]benzamide

IUPAC name

345-trimethoxy-N-[2-(piperidin-1-yl)-5-(1H-1234-tetrazol-1-yl)phenyl]benzamide

SMILES

COc1cc(C(Nc(cc(cc2)-n3nnnc3)c2N2CCCCC2)=O)cc(OC)c1OC

InChI

InChI=1S/C22H26N6O4/c1-30-19-11-15(12-20(31-2)21(19)32-3)22(29)24-17-13-16(28-14-23-25-26-28)7-8-18(17)27-9-5-4-6-10-27/h7-8,11-14H,4-6,9-10H2,1-3H3,(H,24,29)

InChI Key

NKPYWJVJDTYRGV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27171823

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.49

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.185

Distribution Coefficient, logD

3.184

Water Solubility, LogSw

-3.63

Polar Surface Area

88.527

Acid Dissociation Constant (pKa)

10.28

Base Dissociation Constant (pKb)

2.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

F517-0326 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with F517-0326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F517-0326?
Check Price and Availability of F517-0326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F517-0326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F517-0326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F517-0326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F517-0326 available by request